Keybank National Association Genmab A/S Transaction History
Keybank National Association
- $23.9 Billion
- Q1 2024
A detailed history of Keybank National Association transactions in Genmab A/S stock. As of the latest transaction made, Keybank National Association holds 31,588 shares of GMAB stock, worth $854,455. This represents 0.0% of its overall portfolio holdings.
Number of Shares
31,588
Previous 32,187
1.86%
Holding current value
$854,455
Previous $1.02 Million
7.81%
% of portfolio
0.0%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding GMAB
# of Institutions
242Shares Held
47.6MCall Options Held
31.3KPut Options Held
38.7K-
Alliancebernstein L.P. New York, NY15.3MShares$413 Million0.17% of portfolio
-
Black Rock Inc. New York, NY5.07MShares$137 Million0.0% of portfolio
-
Capital International Investors Los Angeles, CA4.37MShares$118 Million0.03% of portfolio
-
Harding Loevner LP Bridgewater, NJ3.29MShares$89.1 Million0.63% of portfolio
-
Wellington Management Group LLP Boston, MA2.33MShares$63.1 Million0.01% of portfolio
About GENMAB A/S
- Ticker GMAB
- Exchange OTC
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 658,292,992
- Market Cap $17.8B
- Description
- Genmab A/S develops antibody therapeutics for the treatment of cancer and other diseases primarily in Denmark. The company markets DARZALEX, a human monoclonal antibody for the treatment of patients with multiple myeloma (MM); teprotumumab for the treatment of thyroid eye disease; ofatumurnab, a human monoclonal antibody to treat chronic lymphoc...